1-243489049-C-G

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_006642.5(SDCCAG8):​c.2021C>G​(p.Ala674Gly) variant causes a missense change. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. 13/22 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. A674V) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)

Consequence

SDCCAG8
NM_006642.5 missense

Scores

5
14

Clinical Significance

Uncertain significance no assertion criteria provided U:1

Conservation

PhyloP100: 4.14

Publications

0 publications found
Variant links:
Genes affected
SDCCAG8 (HGNC:10671): (SHH signaling and ciliogenesis regulator SDCCAG8) This gene encodes a centrosome associated protein. This protein may be involved in organizing the centrosome during interphase and mitosis. Mutations in this gene are associated with retinal-renal ciliopathy. [provided by RefSeq, Oct 2010]
AKT3 (HGNC:393): (AKT serine/threonine kinase 3) The protein encoded by this gene is a member of the AKT, also called PKB, serine/threonine protein kinase family. AKT kinases are known to be regulators of cell signaling in response to insulin and growth factors. They are involved in a wide variety of biological processes including cell proliferation, differentiation, apoptosis, tumorigenesis, as well as glycogen synthesis and glucose uptake. This kinase has been shown to be stimulated by platelet-derived growth factor (PDGF), insulin, and insulin-like growth factor 1 (IGF1). Alternatively splice transcript variants encoding distinct isoforms have been described. [provided by RefSeq, Jul 2008]
AKT3 Gene-Disease associations (from GenCC):
  • overgrowth syndrome and/or cerebral malformations due to abnormalities in MTOR pathway genes
    Inheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
  • megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome 2
    Inheritance: AD Classification: STRONG Submitted by: Genomics England PanelApp, Illumina, Labcorp Genetics (formerly Invitae)
  • megalencephaly-polymicrogyria-postaxial polydactyly-hydrocephalus syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • microcephaly
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.24892312).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
SDCCAG8NM_006642.5 linkc.2021C>G p.Ala674Gly missense_variant Exon 17 of 18 ENST00000366541.8 NP_006633.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
SDCCAG8ENST00000366541.8 linkc.2021C>G p.Ala674Gly missense_variant Exon 17 of 18 1 NM_006642.5 ENSP00000355499.3 Q86SQ7-1
SDCCAG8ENST00000435549.1 linkc.1124C>G p.Ala375Gly missense_variant Exon 10 of 11 1 ENSP00000410200.1 A0A0C4DG71
AKT3ENST00000336199.9 linkc.*7-599G>C intron_variant Intron 13 of 13 1 ENSP00000336943.5 Q9Y243-2
SDCCAG8ENST00000497459.1 linkn.100C>G non_coding_transcript_exon_variant Exon 2 of 3 2

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
Cov.:
32
GnomAD4 genome
Cov.:
33

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: no assertion criteria provided
LINK: link

Submissions by phenotype

SDCCAG8-related disorder Uncertain:1
Aug 07, 2024
PreventionGenetics, part of Exact Sciences
Significance:Uncertain significance
Review Status:no assertion criteria provided
Collection Method:clinical testing

The SDCCAG8 c.2021C>G variant is predicted to result in the amino acid substitution p.Ala674Gly. To our knowledge, this variant has not been reported in the literature or in a large population database, indicating this variant is rare. At this time, the clinical significance of this variant is uncertain due to the absence of conclusive functional and genetic evidence. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.20
BayesDel_addAF
Benign
-0.0045
T
BayesDel_noAF
Benign
-0.24
CADD
Uncertain
25
DANN
Uncertain
1.0
DEOGEN2
Benign
0.035
T;T
Eigen
Uncertain
0.52
Eigen_PC
Uncertain
0.57
FATHMM_MKL
Uncertain
0.94
D
LIST_S2
Benign
0.84
.;T
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.25
T;T
MetaSVM
Benign
-0.83
T
MutationAssessor
Benign
1.6
L;.
PhyloP100
4.1
PrimateAI
Benign
0.45
T
PROVEAN
Benign
-1.9
N;N
REVEL
Benign
0.17
Sift
Uncertain
0.012
D;T
Sift4G
Benign
0.072
T;T
Polyphen
1.0
D;.
Vest4
0.45
MutPred
0.21
Loss of MoRF binding (P = 0.1325);.;
MVP
0.67
MPC
0.071
ClinPred
0.90
D
GERP RS
5.6
Varity_R
0.17
gMVP
0.080
Mutation Taster
=86/14
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

hg19: chr1-243652351; API